Use of gdnf for treating corneal defects

Details Use of gdnf for treating corneal defects Use of gdnf for treating corneal defects

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61K 38/48 (2006.01) A61P 27/02 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2385929

The present invention relates to the use of a glial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/or a nucleic acid containing at least a nucleotide sequence encoding the primary amino acid sequence of GDNF or the functionally active derivative or part thereof and/or of the agonist for the manufacture of a pharmaceutical composition for epidermal and stromal wound healing.

La présente invention concerne l'utilisation d'un facteur de croissance neurotrophique issu des cellules gliales (GDNF) ou d'un dérivé ou d'une partie fonctionnellement active de ce dernier et/ou d'un agoniste qui remplace l'activité fonctionnelle du GDNF, et/ou d'un acide nucléique contenant au moins une séquence nucléotidique codant la séquence d'acides aminés primaire du GDNF ou du dérivé ou la partie fonctionnellement active et/ou de l'agoniste de ce dernier dans la fabrication d'une composition pharmaceutique destinée à la cicatrisation des plaies épidermiques et stromales.

Affiliated with

Also associated with

Rating

Use of gdnf for treating corneal defects does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of gdnf for treating corneal defects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of gdnf for treating corneal defects will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1930710